Literature DB >> 28782876

Portal vein thrombosis after hepatitis C eradication with direct acting antiviral therapy.

Jonathan G Stine1, Shaurya Prakash2, Patrick G Northup1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28782876     DOI： 10.1111/liv.13537

Source DB:  PubMed          Journal:  Liver Int        ISSN： 1478-3223            Impact factor:   5.828


× No keyword cloud information.
  3 in total

1.  Host pharmacogenetic factors that may affect liver neoplasm incidence upon using direct-acting antivirals for treating hepatitis C infection.

Authors:  Ahmad M Zidan; Eman A Saad; Nasser E Ibrahim; Medhat H Hashem; Amal Mahmoud; Alaa A Hemeida
Journal:  Heliyon       Date:  2021-05-03

2.  Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis.

Authors:  Jonathan G Stine; Blake A Niccum; Alex N Zimmet; Nicolas Intagliata; Stephen H Caldwell; Curtis K Argo; Patrick G Northup
Journal:  Clin Transl Gastroenterol       Date:  2018-03-06       Impact factor: 4.488

3.  Prediction of the Factors Influencing the Shengjing Classification of Portal Vein Thrombosis after Splenectomy for Portal Hypertension in Cirrhosis: A Single-Center Retrospective Case-Control Study.

Authors:  Zimin Song; Hanxin Feng; Chunbo Yang; Chaoliu Dai
Journal:  Biomed Res Int       Date:  2020-09-07       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.